MedPath

IRIS-BioFreedom Cohort in the IRIS-DES Registry

Recruiting
Conditions
Coronary Stenosis
Registration Number
NCT03190057
Lead Sponsor
Seung-Jung Park
Brief Summary

The objective of this study is to evaluate effectiveness and safety of BIOFREEDOM™ FAMILY stent in the "real world" daily practice as compared with other drug-eluting stents.

Detailed Description

BIOFREEDOM™ FAMILY stent means that Biofreedom stent, Biofreedom Ultra and the other stents with names starting with Biofreedom.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Age 19 and more
  • Patient with BIOFREEDOM™ FAMILY stent
  • Written consent
Exclusion Criteria
  • Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time
  • Life-expectancy less than 1 year
  • Cardiac shock

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)1 year
Secondary Outcome Measures
NameTimeMethod
All cause death5 year
Cardiac death5 year
Myocardial Infarction5 year
Composite event rate of death or myocardial infarction (MI)5 year
Composite event rate of cardiac death or myocardial infarction (MI)5 year
Target- Vessel Revascularization5 year
Target- Lesion Revascularization5 year
Stent thrombosis5 year
Stroke5 year
Procedural Success rate5 day

defined as achievement of a final diameter stenosis of \<30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization.

Trial Locations

Locations (17)

Hallym University Sacred Heart Hospital

🇰🇷

Anyang, Korea, Republic of

Soonchunhyang University Hospital, Cheonan

🇰🇷

Cheonan, Korea, Republic of

Gangwon National Univ. Hospital

🇰🇷

Chuncheon, Korea, Republic of

Daegu Catholic University Medical Center

🇰🇷

Daegu, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

The Catholic University of Korea, Daejeon ST. Mary's Hospital

🇰🇷

Daejeon, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

Inje University Ilsan Paik Hospital

🇰🇷

Ilsan, Korea, Republic of

Gachon University Gil Hospital

🇰🇷

Incheon, Korea, Republic of

Scroll for more (7 remaining)
Hallym University Sacred Heart Hospital
🇰🇷Anyang, Korea, Republic of
Kyoung-ha Park, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.